期刊文献+

ROS-MAPK通路在肿瘤多药耐药中的逆转作用 被引量:6

在线阅读 下载PDF
导出
摘要 正肿瘤是世界上威胁人类健康的重要疾病之一。根据Jemal A等[1]报道全球癌症组织GLOBOCAN2011年的数据,在2008年新增癌症病例近1 270万人;因癌症死亡760万人[1]。而肿瘤的多药耐药(Multidrug resistance,MDR)现象亦是临床面临的主要问题。
出处 《湖北医药学院学报》 CAS 2012年第6期509-513,共5页 Journal of Hubei University of Medicine
  • 相关文献

参考文献3

二级参考文献73

  • 1盖晓东,曾常茜,洪敏.柴胡逆转肝细胞癌多药耐药作用与相关机制的研究[J].高等学校化学学报,2005,26(8):1446-1450. 被引量:21
  • 2Ryung-Ah Lee,Hyun-Ah Kim,Bo-Young Kang,Kwang-Ho Kim.Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species[J].World Journal of Gastroenterology,2006,12(35):5644-5650. 被引量:1
  • 3DEAN M,RZHETSKY A,ALLIKMETS R.The human ATP-binding cassette (ABC) transporter superfamily[J].Genome Res,2001,11:1156-1166.
  • 4EFFERTH T.The human ATP-binding cassette transporter genes:from the bench to the bedside[J].Curr Mol Med,2001,1:45-65.
  • 5HYDE S C,EMSLEY P,HARTSHORN M J,et al.Structural model of ATP-binding proteins associated with cystic fibrosis,multidrug resistance and bacterial transport[J].Nature,1990,346:362-365.
  • 6ABELE R,TAMPE R.The ABCs of immunology:structure and function of TAP,the transporter associated with antigen processing[J].Physiology (Bethesda),2004,19:216-224.
  • 7FROMM M F.Importance of P-glycoprotein at blood–tissue barriers[J].Trends Pharmacol Sci,2004,25:423-429.
  • 8BORST P,ELFERINK R O.Mammalian ABC transporters in health and disease[J].Ann Rev Biochem,2002,71:537-592.
  • 9FLETCHER J I,HABER M,HENDERSON M J,et al.ABC transporters in cancer:more than just drug efflux pumps[J].Nat Rev Cancer,2010,10:147-156.
  • 10HIGGINS C F.Multiple molecular mechanisms for multidrug resistance transporters[J].Nature,2007,446:749-757.

共引文献65

同被引文献55

  • 1邓守恒,孙各琴,朱名安,周有利,邓守明,陈崇宏.硒化壳聚糖对K562细胞的作用及其与NF-КB信号分子的关系[J].陕西医学杂志,2005,34(12):1472-1474. 被引量:8
  • 2邓守恒,孙各琴,周有利,邓守明,毛达勇.硒化壳聚糖对K562和K562/ADM作用的比较研究[J].广东微量元素科学,2005,12(12):28-30. 被引量:2
  • 3孙兰萍,张胜义,许晖.硒化壳聚糖的制备及理化性质的研究[J].食品工业科技,2006,27(2):145-146. 被引量:36
  • 4韩锐.抗癌药物研究与实验技术[M].北京:北京医科大学、中国协和医科大学联合出版社,1996.440.
  • 5Brien SG, Guilhot F, Larson AR,et al. Imatinib compared with interfer-on and low - dose cytarabine for newly diagnose dehronie - phase chro-nic myeloid leukemia[ J]. N Engl J Med,2003 ,348( 11 ) :994.
  • 6Melo JV,Deininger MW, Goldman JM. The molecular biology of chronicmyeloid leukemia[ J]. Blood,2000,96( 10) :3343.
  • 7Bhatia R,Holtzl M,Niu N,et al. Persistence of malignant hematopoieticprogenitors in chronic myelogenous leukemia patients in complete cyto-genetic remission following imatinibmesylate treatment [ J ]. Blood,2003,101(12) :4701.
  • 8Mahon FX, Belloe F, Lagarde V,et al. MDR1 gene over expression con-fers resistance to imatinib mesylate in leukemia cell line models [ J ].Blood,2003,101 (6) :2368.
  • 9Cheol W. Choi,Dae H. Kang,Hyung W. Kim,Su B. Park,Woo S. Jo,Geun A. Song,Mong Cho.Comparison of Endoscopic Resection Therapies for Rectal Carcinoid Tumor: Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection Using Band Ligation[J].Journal of Clinical Gastroenterology.2013(5)
  • 10Xi‐Feng Jin,Qing‐Yan Sun,Tong‐Hai Chai,Shu‐hui Li,Yan‐li Guo.Clinical value of multiband mucosectomy for the treatment of squamous intraepithelial neoplasia of the esophagus[J].J Gastroenterol Hepatol.2013(4)

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部